The Centers for Disease Control and Prevention opened three public comment periods Monday on what researchers should aim for when developing a human West Nile vaccine, a rapid test and preventive antibody products. The agency will accept comments through Jan. 15, 2027. The notices ask for feedback on proposed goals. The CDC says the U.S. still has no licensed West Nile vaccine for people.
West Nile usually spreads through mosquito bites. Most people who are infected never develop symptoms, but some become very ill. The CDC estimates that about 2,000 people are diagnosed in the U.S. each year, a count that misses many infections. Its November surveillance report notes that mild illness is especially likely to go unreported.
What the three notices cover

The vaccine notice asks whether a vaccine would be valuable for preventing disease and whether enough people would use it to support a commercial market. The agency is also asking the public to comment on the proposed characteristics of a vaccine. A target product profile gives developers a set of goals. The notice neither approves a product nor announces a trial or a vaccination program.
A second notice deals with a rapid test to help identify West Nile illness in people who may already be infected. That would serve a different purpose from a vaccine. A third notice asks about monoclonal antibodies for prevention, a separate proposed way to protect people before they develop illness. The CDC created a separate docket for each, so a comment about one product should go to the corresponding notice.
What the case reports can tell you

The California Department of Public Health reported 560 people who tested positive in 24 counties as of Nov. 13. In its latest weekly report, Los Angeles County accounted for 22 of the 31 newly reported cases statewide. Those figures count reports received during the week. They do not show when each person was infected. The CDC’s national surveillance page uses a Nov. 10 cutoff, so its totals and newer state reports can differ.
For people in areas where mosquitoes remain active, the CDC recommends avoiding bites with EPA-registered insect repellent, loose long sleeves and pants, and intact window and door screens. Empty, scrub or cover outdoor containers that hold water to reduce mosquito breeding sites.
How to submit a comment
Use Regulations.gov and search for CDC-2026-1686 for the vaccine, CDC-2026-1684 for the test or CDC-2026-1685 for the antibody products. The Federal Register notices also give a mailing address. The agency says it does not take comments by email and may post personal details that people include in a submission. All three dockets have the same Jan. 15 deadline.






